Diabetic atherosclerosis mouse models
Authors:
- Kenneth K. WuKWKenneth K. Wu
- Youming HuanYHYouming Huan
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 191 (2) , 241-249
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Type 2 diabetes, dyslipidemia, and vascular risk: Rationale and evidence for correcting the lipid imbalanceAmerican Heart Journal, 2005
- Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic miceJournal of Clinical Investigation, 2005
- Prevention Conference VI: Diabetes and Cardiovascular DiseaseCirculation, 2002
- Prevention Conference VI: Diabetes and Cardiovascular DiseaseCirculation, 2002
- Diabetes and Cardiovascular Disease Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart AssociationCirculation, 2002
- Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: Insights into the pathogenesis of macrovascular complications in diabetesCurrent Atherosclerosis Reports, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Mouse models of hyperlipidemia and atherosclerosisFrontiers in Bioscience-Landmark, 2001
- The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and AtherothrombosisEuropean Journal of Cardiovascular Risk, 2000
- Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994Diabetes Care, 1998